Nemonapride

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Nemonapride
Nemonapride.svg
Clinical data
Trade names Emilace (JP)
AHFS/Drugs.com International Drug Names
Routes of
administration
Oral
ATC code
  • none
Legal status
Legal status
  • Rx-only (JP)
Identifiers
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
PDB ligand
ECHA InfoCard 100.215.765 Edit this at Wikidata
Chemical and physical data
Formula C21H26ClN3O2
Molar mass 387.90 g/mol
3D model (JSmol)
  (verify)

Nemonapride (エミレース, Emilace (JP)) is an atypical antipsychotic approved in Japan for the treatment of schizophrenia. It was launched by Yamanouchi in 1991. Nemonapride acts as a D2 and D3 receptor antagonist, and is also a potent 5-HT1A receptor agonist. It has affinity for sigma receptors.

See also[edit]

References[edit]